PA-PMI
31.1.2020 17:32:11 CET | Business Wire | Press release
To truly deliver value to their organizations and society as a whole, project leaders need insight on the future of major business, technological, economic and geopolitical trends. To help project leaders achieve this, Project Management Institute (PMI), the world’s leading association for the project, program and portfolio management profession, released its latest Signposts Report to the public. The report explores key takeaways on global, long-term trends across a range of issue areas and assesses how these complexities are impacting the world.
PMI’s Strategy and Growth team has been developing the Signpost report annually to help discern where the world is moving and how industry project leaders can prepare for the future, but historically kept the report an internal resource. Given this time of profound global change, PMI is making these insights public for the first time. This new public-facing report identifies and explores six key takeaways from the 11 over-arching Signposts so that project leaders have the information they need to turn ideas into reality.
“Our world is going through a tremendous amount of change, which will inevitably have an effect on the work of project leaders, as well as our everyday life,” said Sunil Prashara, President and CEO of Project Management Institute. “Project leaders must have a deep understanding of the trends shaping the world. While these trends create challenges for project leaders, they also create opportunities for project managers to foster solutions and truly deliver value to their organizations and society alike.”
The report, which draws on trend research, as well as interviews with project professionals, news reports and industry data, includes the following insights:
- The next generation of project professionals will derive from Africa and most of the developing world : The highest proportion of 25- to 34-year-olds are found in Africa, the Middle East, Southeast Asia, and South and Central America, making the region ripe with career opportunities for young project professionals looking to play a role in upgrading their respective regions’ transportation, water management and energy infrastructure. But while young talent might be eager, they’re also inexperienced—and will need guidance in navigating a complex project landscape.
- Project managers can play a pivotal role in avoiding the global risks and threats associated with climate change : To balance economic development with environmental sustainability, project leaders need to start thinking differently. As the face of the planet is reshaped, project professionals will find themselves leading projects in water management, environmental sustainability, renewable energy and more. Reimagining how communities exist will help preserve quality of life in many regions, and project leaders are positioned to play a pivotal role in making that preservation happen.
- The rapid rise of AI will reward those with strong technical and people skills : Artificial intelligence (AI) has the potential to usher in an era of innovation that will improve humanity in ways we can’t even begin to fathom. The responsibility rests with project leaders to help make the most of the technology, while mitigating the risks to society. Project professionals already manage 23 percent of initiatives using AI and expect that will jump to 37 percent over the next three years, according to PMI’s AI Innovators: Cracking the Code on Project Performance .
- Rampant protectionism is threatening globalization; however many international project teams may move through unscathed : While the business world has long been defined by its massive global scale, the sheer scope of globalization took an economic toll on many communities, leading to a wave of increasingly protectionist—and even discriminatory—trade, immigration and work policies. Isolationism places further stress on efficient planning and execution of projects for multinational, multiethnic and geographically distributed teams. Project leaders excel when collaborating across time zones, no matter the geopolitical tensions—making them a great case study in the power of globalization.
- Project leaders will be tasked with closing the gap between global infrastructure needs and investment : As urban population centers swell, climate change intensifies and emerging economies mature, demand for water, roads, airports, ports, electrical grids and communication networks also increases. There’s a bit of history to overcome here, with infrastructure megaprojects infamously prone to cost overruns and delays. While many teams are turning to technology to depart from this trend, project leaders will still need good, old-fashioned people skills to create stronger societal consensus.
- Cybersecurity requires transformation in not only technology, but also culture : Cybersecurity attacks are varied, from the theft of an individual’s banking password to the full-on infiltration of increasingly tech-driven pieces of critical physical infrastructure, such as a power grid or a public transit system. With such complex technologies, project leaders must forge ties across organizations while seeking out innovation. This means project professionals will need not only technical prowess, but stellar leadership and stakeholder engagement skills, too.
As a new decade ushers in a world full of complex issues, it’s clear we need to reimagine the nature of work and how it gets done. The demand for versatile and bold project talent—capable of embracing new ways of working, leading diverse teams, and exploring innovative solutions for delivering value—is likely to increase. By understanding the world’s transformation, project leaders will be better poised to seize the opportunities that lie ahead in The Project Economy , where organizations will deliver financial and societal value to stakeholders through successful completion of projects, delivery of products, and alignment to value streams.
Read the latest Signposts Report here .
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org , www.projectmanagement.com , www.facebook.com/PMInstitute and on Twitter @PMInstitute.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200131005419/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 08:00:00 CET | Press release
Clinical and preclinical presentations reflect the company’s ongoing exploration of peripheral neuropathic pain Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greates
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
